Share this article:

San Clemente-based Cameron Health Inc. will have its implantable heart defibrillator reviewed by an FDA panel on April 26, the company said.

Cameron is being bought for $150 million plus more than $1 billion in potential payments by Boston Scientific Corp. of Natick, Mass., a longtime investor. An approval by the FDA would bring the first $150 million in milestone payments included in the deal.

Get the latest OC business updates for FREE

That deal is expected to be completed in this year’s second or third quarter.

The company makes the S-ICD, an implantable defibrillator that delivers electric shocks to people suffering from heart attacks. S-ICD is implanted subcutaneously, eliminating the need for lead wire placement inside the heart.

Cameron Chief Executive Kevin Hykes called the meeting “a significant step” toward getting approval for S-ICD. S-ICD has European approval.